Allez Health

Allez Health is an emerging player in the biosensor space, developing next-generation continuous monitors for glucose and lactate. The company's core strength lies in its proven leadership team, which includes the lead inventor and key developers of a major commercial CGM system, suggesting strong technical credibility. While still in development, the company has achieved a significant regulatory milestone with NMPA approval for the China market for its glucose sensor, indicating advanced progress. Allez Health is positioning itself to disrupt the metabolic sensing market with a focus on high accuracy and person-centric health solutions.

Next-generation electrochemical biosensor platform for continuous, multi-analyte monitoring (glucose, lactate), focusing on high accuracy and stability through advanced sensor chemistry and membrane design.

In CGM, Allez faces dominant, well-funded incumbents (Dexcom, Abbott, Medtronic) and other innovators. Its differentiation is based on accuracy claims and a seasoned team. In lactate sensing, the competitive field is nascent, offering a first-mover advantage but requiring significant effort to establish clinical utility and market demand.